Evidence map›Paper›PMID 30511950›Full record

ArticleJournal of musculoskeletal & neuronal interactions2018

Translation and validation of the Dutch SarQoL

Anton Geerinck, Annelies Scheppers, Charlotte Beaudart, Olivier Bruyère, Wim Vandenbussche, René Bautmans, Sam Delye, Ivan Bautmans

Abstract read
In one paragraph

Article in Journal of musculoskeletal & neuronal interactions, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Analysis of Structural Characteristics and Psychometric Properties of the SarQoLInternational journal of environmental research and public health · 2022
    Pooled it
  4. Article
  5. Validation of the German version of the SarQoLAging clinical and experimental research · 2024
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Assessment of the performance of the SarQoLAging clinical and experimental research · 2021
    Article
  14. Development and validation of a short version of the Sarcopenia Quality of Life questionnaire: the SF-SarQoL.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2021
    Article
  15. Article
  16. Translation and validation of the Korean version of the Sarcopenia Quality of Life (SarQoL-K®) questionnaire and applicability with the SARC-F screening tool.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2021
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Anton GeerinckDepartment of Public Health, Epidemiology and Health Economics, University of Liège, Belgium.
Annelies Scheppers
Charlotte Beaudart
Olivier Bruyère
Wim Vandenbussche
René Bautmans
Sam Delye
Ivan Bautmans

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo translate the Sarcopenia Quality of Life (SarQoL

methodsThe translation was carried out using a 5-step process, with 2 initial translations, a merging of these 2 translations, 2 backwards translations, an expert committee review and a pretest of the questionnaire. Sarcopenia was diagnosed with the EWGSOP algorithm. The validation consisted of an examination of the discriminative power, internal consistency, construct validity, test-retest reliability and floor and ceiling effects.

resultsNo significant problems were encountered during the translation process. A total of 92 subjects were included in the validation part of this study, 30 of which were sarcopenic. Discriminative power between sarcopenic and non-sarcopenic subjects was found for all domains and the Overall score (median overall QoL score: 67.15 vs 79.72; p=0.003). High internal consistency was found (Cronbach's alpha=0.883), as well as good construct validity with 75% of hypotheses confirmed. Test-retest reliability was excellent (ICC=0.976; 95% CI=0.947-0.989) and no floor or ceiling effects were observed.

conclusionThe Dutch version of the SarQoL

Indexed as

TranslationsActivities of Daily LivingAgedAged, 80 and overBelgiumFemaleHumansMaleQuality of LifeReproducibility of ResultsSarcopeniaSurveys and Questionnaires

Identifiers

PMID30511950
PMCPMC6313042

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.